The Evolution of Therapies in Non-Small Cell Lung Cancer

The landscape of advanced non-small lung cancer (NSCLC) therapies has rapidly been evolving beyond chemotherapy over the last few years. The discovery of oncogenic driver mutations has led to new ways in classifying NSCLC as well as offered novel therapeutic targets for anticancer therapy. Targets s...

Descripción completa

Detalles Bibliográficos
Autores principales: Boolell, Vishal, Alamgeer, Muhammad, Watkins, David N., Ganju, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586797/
https://www.ncbi.nlm.nih.gov/pubmed/26371045
http://dx.doi.org/10.3390/cancers7030864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586797/
https://www.ncbi.nlm.nih.gov/pubmed/26371045
http://dx.doi.org/10.3390/cancers7030864

Ejemplares similares